Explore All Access
Check if your research matches the topics covered in Drug Resistance Updates?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Drug Resistance Updates : Impact Factor & More
eISSN: 1532-2084pISSN: 1368-7646
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Drug Resistance Updates Key Metrics
CiteScore 
30.8
Eigenfactor
0.001 - 0.005
H-Index
125
Impact Factor
20 - 25
SJR
Q1Oncology
SNIP
3.67
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months40%
4 to 6 months42%
7 to 9 months17%
Above 9 months2%
Did you find this useful?
Topics Covered on Drug Resistance Updates
Clinical evidence
Ovarian cancer
Immunotherapy
Glioblastoma
Bacterial persistence
Antitumor immunity
Drug resistance
Homologous recombination
Prostate cancer
Paclitaxel
Autophagy
Tumor microenvironment
Drug response
High-grade serous carcinoma
Enterococcus
Tumor immunity
Homologous Recombination Deficiency
Docetaxel
Vancomycin resistance
Immune checkpoint inhibitors
Drug Resistance Updates Journal Specifications
| Overview | |
| Publisher | CHURCHILL LIVINGSTONE |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1998 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Drug Resistance Updates ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Drug Resistance Updates
TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4
- 1 Jan 2025
- Drug Resistance Updates
Global phylogeography and antibiotic resistance characteristics of Morganella: An epidemiological, spatial, comparative genomic study
- 1 Jan 2025
- Drug Resistance Updates
Reshaping the Battlefield: A Decade of Clonal Wars Among Staphylococcus aureus in China
- 1 Jan 2025
- Drug Resistance Updates
Association of idealized amphiphiles and protease inhibitors: conferring antimicrobial peptides with stable antibacterial activity under physiological conditions to combat multidrug-resistant bacteria
- 1 Dec 2024
- Drug Resistance Updates
CEA-Induced PI3K/AKT Pathway Activation through the Binding of CEA to KRT1 Contributes to Oxaliplatin Resistance in Gastric Cancer
- 1 Dec 2024
- Drug Resistance Updates
Editorial on “Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling”
- 1 Dec 2024
- Drug Resistance Updates
TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4
- 1 Jan 2025
- Drug Resistance Updates
Global phylogeography and antibiotic resistance characteristics of Morganella: An epidemiological, spatial, comparative genomic study
- 1 Jan 2025
- Drug Resistance Updates
Reshaping the Battlefield: A Decade of Clonal Wars Among Staphylococcus aureus in China
- 1 Jan 2025
- Drug Resistance Updates
Association of idealized amphiphiles and protease inhibitors: conferring antimicrobial peptides with stable antibacterial activity under physiological conditions to combat multidrug-resistant bacteria
- 1 Dec 2024
- Drug Resistance Updates
CEA-Induced PI3K/AKT Pathway Activation through the Binding of CEA to KRT1 Contributes to Oxaliplatin Resistance in Gastric Cancer
- 1 Dec 2024
- Drug Resistance Updates
Editorial on “Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling”
- 1 Dec 2024
- Drug Resistance Updates
Compare Similar Journals with Drug Resistance Updates
Select Journals to Compare with Drug Resistance Updates
Total journals - 9
You can select up to 3 Journals at a time
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Cancers
Publisher: MDPI
International Journal of Molecular Sciences
Publisher: MDPI
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Scientific Reports
Publisher: NATURE PORTFOLIO
Oncotarget
Publisher: Impact Journals
Cells
Publisher: MDPI
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
0 Journals Selected to compare with
Drug Resistance Updates
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Drug Resistance Updates
How long has Drug Resistance Updates been actively publishing? 
Drug Resistance Updates has been in operation since 1998 till date.
What is the publishing frequency of Drug Resistance Updates?
Drug Resistance Updates published with a Bi-monthly frequency.
How many articles did Drug Resistance Updates publish last year?
In 2023, Drug Resistance Updates publsihed 98 articles.
What is the eISSN & pISSN for Drug Resistance Updates?
For Drug Resistance Updates, eISSN is 1532-2084 and pISSN is 1368-7646.
What is Citescore for Drug Resistance Updates?
Citescore for Drug Resistance Updates is 30.8.
What is the H Index for Drug Resistance Updates ?
H Index for Drug Resistance Updates is 125.
What is SNIP score for Drug Resistance Updates?
SNIP score for Drug Resistance Updates is 3.67.
What is the SJR for Drug Resistance Updates?
SJR for Drug Resistance Updates is Q1.
Who is the publisher of Drug Resistance Updates?
CHURCHILL LIVINGSTONE is the publisher of Drug Resistance Updates.
